NV
Vuilleumier, Nicolas
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study | PloS one | 2026 | 25 | 71 | |||
| Biomarkers of Kidney Failure and All-Cause Mortality in CKD | Journal of the American Society of Nephrology | 2025 | 26 | 69 | |||
| Autoimmunity in MASLD : Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors | European journal of clinical investigation | 2025 | 74 | 271 | |||
| Authors' Reply : Novel Biomarkers in CKD | Journal of the American Society of Nephrology | 2025 | 8 | 44 | |||
| Autoantibodies against apolipoprotein A-1 and cadmium : possible links tocardiovascular and liver diseases across multiple models | ESC (European Society of Cardiology) Congress 2025 | 2025 | 9 | 0 | |||
| Autoantibodies against apolipoprotein A-1 and cadmium : Possible links tocardiovascular and liver diseases across multiple models | 93rd EAS (European Atherosclerosis Society) Congress | 2025 | 11 | 0 | |||
| Plasma and Urinary KIM-1 in Chronic Kidney Disease : Prognostic Value, Associations with Albuminuria, and Implications for Kidney Failure and Mortality | American journal of nephrology | 2025 | 16 | 117 | |||
| Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas | The journal of antimicrobial chemotherapy | 2025 | 60 | 103 | |||
| Personalised Care in CKD : Moving Beyond Traditional Biomarkers | The Nephron journals | 2025 | 51 | 325 | |||
| Utility of cardiac biomarkers (NT-proBNP and Hs-Troponin-T) in predicting mortality, cardiovascular and renal outcomes in patients with chronic kidney disease | American journal of nephrology | 2025 | 20 | 162 | |||
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open | 2025 | 96 | 193 | |||
| Geospatial clustering of autoantibodies against apolipoprotein A-1 andenvironmental pollution in the Geneva general population | 93rd EAS (European Atherosclerosis Society) Congress | 2025 | 13 | 0 | |||
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | 2025 | 77 | 289 | |||
| Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children | Frontiers in immunology | 2025 | 54 | 87 | |||
| Autoantibodies to apolipoprotein A-I in hepatitis C virus infection : a role in disease progression? | Frontiers in immunology | 2025 | 35 | 41 | |||
| National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study | Clinical kidney journal | 2024 | 118 | 69 | |||
| Faux positif lié à une macrotroponinémie élevée | Revue médicale suisse | 2024 | 116 | 17 | |||
| Contributions of long-read sequencing for the detection of antimicrobial resistance | Pathogens | 2024 | 260 | 199 | |||
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health | 2024 | 7 | 129 | |||
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 6 | 0 | |||
| People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites : a case–control study | Frontiers in cardiovascular medicine | 2024 | 115 | 40 | |||
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 9 | 0 | |||
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | 2024 | 119 | 175 | |||
| Linking antibody against apolipoprotein A-1 to nonalcoholic steatohepatitis in mice | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 8 | 0 | |||
| Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associatedsteatohepatitis in mice | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 6 | 0 | |||
| Ferritin : a biomarker requiring caution in clinical decision | Diagnostics | 2024 | 100 | 150 | |||
| Associations between high-density lipoprotein particle’s proteome, subfractions and autoantibodies against apolipoprotein A1 in HIV patients | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 9 | 0 | |||
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals,cardiovascular and liver diseases in the general population | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 10 | 0 | |||
| The Impact of Primary Renal Diagnosis on Prognosis and the Varying Predictive Power of Albuminuria in the NURTuRE-CKD Study | American journal of nephrology | 2024 | 107 | 87 | |||
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders | 2024 | 8 | 99 | |||
| Newborn phosphocalcic metabolism after intravenous iron administration during pregnancy | Journal of maternal-fetal & neonatal medicine | 2024 | 114 | 359 | |||
| Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice | International journal of molecular sciences | 2024 | 125 | 134 | |||
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals, cardiovascular and liver diseases in the general population | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 9 | 0 | |||
| Prevalence of and risk factors for suicidal ideation in adolescents during the COVID-19 pandemic : a cross-sectional study | Swiss medical weekly | 2024 | 10 | 32 | |||
| Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health | 2023 | 179 | 197 | |||
| Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Diseaseand cardiovascular risk : a translational study | ESC (European Society of Cardiology) Congress 2023 | 2023 | 5 | 0 | |||
| Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health | 2023 | 161 | 115 | |||
| Recombinant nanobodies detecting the human cardiac troponin proteins by ELISA | Antibody reports | 2023 | 54 | 263 | |||
| Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | 2023 | 177 | 195 | |||
| Comment on: Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages | Rheumatology | 2023 | 85 | 0 | |||
| Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients | Nutrients | 2023 | 700 | 744 | |||
| Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study | Journal of translational medicine | 2023 | 142 | 148 | |||
| Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | 2023 | 148 | 74 | |||
| Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: Methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD) | Nephrology, dialysis, transplantation | 2023 | 129 | 104 | |||
| Straightforward quantification of endogenous steroids with liquid chromatography–tandem mass spectrometry: Comparing calibration approaches | Journal of chromatography. B | 2023 | 134 | 207 | |||
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | 2023 | 131 | 87 | |||
| Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease | Biomolecules | 2023 | 76 | 164 | |||
| Multitargeted Internal Calibration for the Quantification of Chronic Kidney Disease-Related Endogenous Metabolites Using Liquid Chromatography–Mass Spectrometry | Analytical chemistry | 2023 | 135 | 88 | |||
| Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study | Occupational and environmental medicine | 2022 | 251 | 98 | |||
| Internal calibration as an emerging approach for endogenous analyte quantification: Application to steroids | Talanta | 2022 | 404 | 514 | |||
| Anti‐SARS-CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1? | European journal of clinical investigation | 2022 | 244 | 139 | |||
| Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open | 2022 | 234 | 86 | |||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 172 | 218 | |||
| Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I | Research and practice in thrombosis and haemostasis | 2022 | 194 | 423 | |||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | 2022 | 119 | 141 | |||
| GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation | Nature cardiovascular research | 2022 | 219 | 49 | |||
| High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? | 90th European Atherosclerosis Society (EAS) congress | 2022 | 157 | 0 | |||
| Feasibility of home-based ELISA capillary blood self-testing for anti-SARS-CoV-2 antibodies | Practical laboratory medicine | 2022 | 231 | 129 | |||
| A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents | Nature communications | 2022 | 220 | 141 | |||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 94 | 0 | |||
| Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation | Bone marrow transplantation | 2022 | 146 | 171 | |||
| Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study | Obesity surgery | 2022 | 368 | 155 | |||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 446 | 161 | |||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 159 | 156 | |||
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases | Frontiers in immunology | 2022 | 204 | 91 | |||
| Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA | RMD open | 2022 | 121 | 102 | |||
| Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis | International journal of infectious diseases | 2022 | 213 | 215 | |||
| Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | 2021 | 265 | 169 | |||
| Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP | Neurology: Neuroimmunology & Neuroinflammation | 2021 | 918 | 366 | |||
| Performances of automated digital imaging of Gram-stained slides with on-screen reading against manual microscopy | European Journal of Clinical Microbiology & Infectious Diseases | 2021 | 238 | 200 | |||
| Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis | The Lancet. Rheumatology | 2021 | 182 | 182 | |||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 441 | 256 | |||
| Gene regulation contributes to explain the impact of early life socioeconomic disadvantage on adult inflammatory levels in two cohort studies | Scientific reports | 2021 | 257 | 267 | |||
| Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications | 2021 | 263 | 192 | |||
| SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 383 | 38 | |||
| Anti‐ApoA‐1 IgGs predict resistance to waist circumference reduction after Mediterranean diet | European journal of clinical investigation | 2021 | 206 | 0 | |||
| Prognostic value of total testosterone levels in patients with acute coronary syndromes | European Journal of Preventive Cardiology | 2021 | 489 | 3 | |||
| Prevalence of immunoglobulin G (IgG) against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) andeEvaluation of a rapid MEDsan IgG test in children seeking medical care | Clinical Infectious Diseases | 2021 | 302 | 341 | |||
| Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | 2021 | 312 | 213 | |||
| Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses | The Lancet. Rheumatology | 2021 | 244 | 189 | |||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study | Scandinavian journal of public health | 2021 | 355 | 172 | |||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 303 | 294 | |||
| Lipoprotein(a) levels are not independently associated with endogenous steroid hormone levels, in contrast to other non-genetic and genetic factors: the population-based SKIPOGH study | European heart journal | 2021 | 243 | 0 | |||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 410 | 231 | |||
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports | 2021 | 258 | 174 | |||
| Changes of lipoprotein(a) levels with endogenous steroid hormones | European journal of clinical investigation | 2021 | 306 | 345 | |||
| SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 422 | 261 | |||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | 2021 | 350 | 267 | |||
| Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia | Journal of clinical medicine | 2021 | 269 | 200 | |||
| Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease | 89th Europen Society of Atherosclerosis (EAS) | 2021 | 142 | 0 | |||
| Performance of Fully Automated Antimicrobial Disk Diffusion Susceptibility Testing Using Copan WASP Colibri Coupled to the Radian In-Line Carousel and Expert System | Journal of Clinical Microbiology | 2021 | 233 | 251 | |||
| Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases | 2021 | 508 | 250 | |||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 343 | 207 | |||
| Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation | 88th EAS (European Atherosclerosis Society) Congress | 2020 | 67 | 0 | |||
| Emerging biomarkers for cardiac arrhythmias | Clinical Biochemistry | 2020 | 316 | 0 | |||
| Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | 2020 | 465 | 259 | |||
| Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution | The Lancet Digital Health | 2020 | 214 | 65 | |||
| Impact of Total Laboratory Automation on Turnaround Times for Urine Cultures and Screening Specimens for MRSA, ESBL, and VRE Carriage: Retrospective Comparison With Manual Workflow | Frontiers in cellular and infection microbiology | 2020 | 188 | 309 | |||
| Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study | PLOS ONE | 2020 | 366 | 301 | |||
| Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | 2020 | 526 | 340 | |||
| Impact of restricting procalcitonin measurements in a Swiss tertiary-care hospital on antibiotic use, clinical outcomes, and costs: An interrupted time-series analysis | Infection Control and Hospital Epidemiology | 2020 | 284 | 90 | |||
| High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases | Metabolism, clinical and experimental | 2020 | 188 | 0 | |||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 783 | 14 | |||
| Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques | International Journal of Molecular Sciences | 2020 | 243 | 128 | |||
| Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion | BioMed research international | 2020 | 179 | 123 | |||
| Rapid identification by MALDI-TOF/MS and antimicrobial disk diffusion susceptibility testing for positive blood cultures after a short incubation on the WASPLab | European Journal of Clinical Microbiology & Infectious Diseases | 2020 | 329 | 2 | |||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 458 | 436 | |||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 380 | 211 | |||
| Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma | PLOS ONE | 2020 | 468 | 342 | |||
| Auto-antibodies against apolipoprotein a-1 block cancer cells proliferation and induce apoptosis | Oncotarget | 2020 | 173 | 127 | |||
| Atherosclerotic plaque vulnerability is increased in mouse model of lupus | Scientific Reports | 2020 | 324 | 235 | |||
| Implementation of the WASPLab™ and first year achievements within a university hospital | European Journal of Clinical Microbiology & Infectious Diseases | 2020 | 269 | 0 | |||
| Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology | 2020 | 207 | 158 | |||
| Comparison of the Copan WASPLab incorporating the BioRad expert system against the SIRscan 2000 automatic for routine antimicrobial disc diffusion susceptibility testing | Clinical Microbiology and Infection | 2020 | 349 | 0 | |||
| C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formation | Atherosclerosis | 2020 | 252 | 0 | |||
| Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters | Frontiers in Public Health | 2020 | 303 | 120 | |||
| High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism | Thrombosis Research | 2019 | 366 | 0 | |||
| Copan WASPLab automation significantly reduces incubation times and allows earlier culture readings | Clinical Microbiology and Infection | 2019 | 300 | 1 | |||
| Antibodies against the C-terminus of apoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus | International Journal of Molecular Sciences | 2019 | 391 | 220 | |||
| Comparison of analytical performances of the Roche Cobas 6800 CT/NG assay with the Abbott m2000 Real Time CT/NG assay for detecting Chlamydia trachomatis and Neisseria gonorrhoeae | Journal of Medical Microbiology | 2019 | 568 | 0 | |||
| Autoantibodies to apolipoprotein A-1 as independent predictors of cardiovascular mortality in renal transplant recipients | Journal of Clinical Medicine | 2019 | 344 | 162 | |||
| Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects | Journal of clinical medicine | 2019 | 240 | 102 | |||
| Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort | Atherosclerosis | 2019 | 438 | 1 | |||
| Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromes | Journal of Clinical Medicine | 2019 | 440 | 194 | |||
| Risk stratification of elderly patients with acute pulmonary embolism | European Journal of Clinical Investigation | 2019 | 380 | 0 | |||
| Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus | Rheumatology | 2019 | 481 | 264 | |||
| Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes | European Journal of Clinical Investigation | 2019 | 400 | 2 | |||
| Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation | Journal of clinical medicine | 2019 | 241 | 188 | |||
| P5343 - The presence of anti-apolipoprotein A1 autoantibodies is associated with a pro-atherogenic profile in HIV-infected patients | ESC Congress 2019 together with World Congress of Cardiology | 2019 | 120 | 0 | |||
| Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular disease | Annals of Clinical Biochemistry | 2019 | 355 | 0 | |||
| Automated incubation and digital image analysis of chromogenic media using copan WASPLab enables rapid detection of vancomycin-resistant enterococcus | Frontiers in Cellular and Infection Microbiology | 2019 | 292 | 156 | |||
| Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease | Journal of Nephrology | 2019 | 400 | 189 | |||
| Deficiency of monoacylglycerol lipase enhances IgM plasma levels and limits atherogenesis in a CB2-dependent manner | Thrombosis and Haemostasis | 2019 | 435 | 0 | |||
| Clinical method evaluation of hemoglobin S and C identification by top-down selected reaction monitoring and electron transfer dissociation | Clinical Proteomics | 2019 | 284 | 265 | |||
| Humoral immunity against HDL particle: a new perspective in cardiovascular diseases? | Current Pharmaceutical Design | 2019 | 276 | 0 | |||
| Infection-induced humoral autoimmunity: a missing link in the interplay between pathogens, dyslipidemia, and innate immunity? | Journal of the American College of Cardiology | 2018 | 302 | 0 | |||
| Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients | Journal of Infection | 2018 | 581 | 1 | |||
| Impact of long distance rowing on biological health: A pilot study | Clinical Biochemistry | 2018 | 568 | 0 | |||
| Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis? | Hepatology International | 2018 | 441 | 260 | |||
| Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation | The Journal of International Medical Research | 2018 | 428 | 237 | |||
| Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America | Journal of Tropical Medicine | 2018 | 751 | 345 | |||
| CRP-Based Cardiovascular Risk Assessment: New Conventional CRP Assay Fit for Purpose? | Journal of Applied Laboratory Medicine (JALM) | 2018 | 470 | 2 | |||
| Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms | Frontiers in Immunology | 2017 | 471 | 242 | |||
| Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population | Arteriosclerosis, Thrombosis, and Vascular Biology | 2017 | 517 | 0 | |||
| Pharmacological Intervention to Modulate HDL: What Do We Target? | Frontiers in Pharmacology | 2017 | 499 | 431 | |||
| Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study | BMC Nephrology | 2017 | 495 | 273 | |||
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | 2016 | 563 | 0 | |||
| Profound hyponatraemia in the emergency department: seasonality and risk factors | Swiss Medical Weekly | 2016 | 518 | 191 | |||
| Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study | Thrombosis and haemostasis | 2016 | 566 | 7 | |||
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes | European heart journal | 2016 | 630 | 2 | |||
| The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD | Clinical Journal of the American Society of Nephrology | 2016 | 423 | 0 | |||
| Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism | PloS one | 2016 | 789 | 317 | |||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | 2016 | 633 | 6 | |||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | 2016 | 770 | 685 | |||
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | 2016 | 517 | 200 | |||
| Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 | Antioxidants & redox signaling | 2015 | 604 | 0 | |||
| Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction | European journal of clinical investigation | 2015 | 634 | 3 | |||
| Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population | European journal of clinical investigation | 2015 | 658 | 0 | |||
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | PloS one | 2015 | 678 | 262 | |||
| Biomarkers for cardiovascular risk assessment in autoimmune diseases | Proteomics. Clinical applications | 2015 | 661 | 2 | |||
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | 2015 | 669 | 0 | |||
| Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | 2015 | 659 | 2 | |||
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | 2015 | 748 | 0 | |||
| CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes | Endocrinology | 2015 | 669 | 1 | |||
| Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions | Handbook of experimental pharmacology | 2015 | 669 | 0 | |||
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | 2015 | 793 | 0 | |||
| The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? | PloS one | 2015 | 562 | 379 | |||
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | 2015 | 608 | 0 | |||
| Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis | Journal of neuroimmunology | 2015 | 629 | 0 | |||
| Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism | Journal of internal medicine | 2015 | 706 | 3 | |||
| Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies | Current drug targets | 2015 | 604 | 0 | |||
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | 2015 | 634 | 5 | |||
| Update on the efficacy of statin treatment in acute coronary syndromes | European journal of clinical investigation | 2014 | 602 | 0 | |||
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | 2014 | 655 | 0 | |||
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | 2014 | 791 | 0 | |||
| Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case | World journal of clinical cases | 2014 | 669 | 0 | |||
| Potential pathophysiological role for the vitamin D deficiency in essential hypertension | World journal of cardiology | 2014 | 586 | 0 | |||
| Inferior vena cava parameters predict re-admission in ischaemic heart failure | European journal of clinical investigation | 2014 | 619 | 0 | |||
| Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases | The Journal of biological chemistry | 2014 | 768 | 643 | |||
| Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis | Thrombosis and haemostasis | 2014 | 652 | 0 | |||
| Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis | Mediators of inflammation | 2014 | 837 | 405 | |||
| Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases | Current medicinal chemistry | 2014 | 766 | 0 | |||
| Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity | World journal of cardiology | 2014 | 663 | 308 | |||
| 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals | Stroke | 2014 | 715 | 3 | |||
| Pathophysiological role of neutrophils in acute myocardial infarction | Thrombosis and haemostasis | 2013 | 611 | 0 | |||
| Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis | Journal of periodontal research | 2013 | 775 | 1 | |||
| Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction | Antioxidants & redox signaling | 2013 | 784 | 807 | |||
| Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy | Thrombosis and haemostasis | 2013 | 740 | 1 | |||
| Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | 2013 | 758 | 0 | |||
| Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins? | Schweizerische medizinische Wochenschrift | 2013 | 784 | 424 | |||
| Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases | Thrombosis and haemostasis | 2013 | 504 | 0 | |||
| Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity | 2013 | 805 | 754 | ||||
| DHEA prevents mineralo- and glucocorticoid receptor-induced chronotropic and hypertrophic actions in isolated rat cardiomyocytes | Endocrinology | 2013 | 544 | 0 | |||
| Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases | Clinical reviews in allergy & immunology | 2013 | 650 | 3 | |||
| The vulnerable coronary plaque: update on imaging technologies | Thrombosis and haemostasis | 2013 | 454 | 0 | |||
| Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals | Mediators of inflammation | 2012 | 655 | 294 | |||
| Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex | Journal of internal medicine | 2012 | 752 | 3 | |||
| Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? | Arthritis care & research | 2012 | 698 | 0 | |||
| High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage | Therapeutic apheresis and dialysis | 2012 | 649 | 0 | |||
| Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction | Journal of internal medicine | 2012 | 671 | 2 | |||
| The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | 2012 | 747 | 0 | |||
| Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability | Thrombosis and haemostasis | 2012 | 796 | 0 | |||
| Inflammatory cardiovascular risk biomarkers: update on novelties and limitations | Mediators of inflammation | 2012 | 514 | 0 | |||
| Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels | Endocrinology | 2012 | 712 | 0 | |||
| Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability | European heart journal | 2011 | 674 | 2 | |||
| Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome | American journal of physiology: endocrinology and metabolism | 2011 | 668 | 0 | |||
| Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism? | Journal of thrombosis and haemostasis | 2010 | 608 | 0 | |||
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | 2010 | 908 | 3 | |||
| Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction | European heart journal | 2010 | 708 | 0 | |||
| Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism | Thrombosis and haemostasis | 2009 | 676 | 780 | |||
| Biomarqueurs cardiaques et embolie pulmonaire : stratification pronostique | Revue médicale suisse | 2009 | 478 | 1 | |||
| Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers | Vascular health and risk management | 2009 | 509 | 296 | |||
| Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study | Journal of thrombosis and haemostasis | 2009 | 657 | 0 | |||
| Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism | Thrombosis research | 2008 | 741 | 0 | |||
| Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome | Clinical science | 2008 | 773 | 9 | |||
| CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis | European journal of clinical pharmacology | 2006 | 664 | 592 | |||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | 2004 | 543 | 0 | |||
| Neuropathological analysis of an adult case of the Cornelia de Lange syndrome | Acta neuropathologica | 2002 | 536 | 0 |
